s.k.safiuddin thesis 0703ph1325 - revision...

ANNEXURE I

CONSISTENTLY LISTED ( FDI and NON-FDI) COMPANIES WITH

FOREIGN PROMOTERS QUOTA (CONSIDERED FOR THE STUDY)

1. List of FDI-based listed Companies

S.No Company Name Holding Date Foreign Promoter (%)

1. Abbott India Ltd. 2010.12.31 68.94

2. Astrazeneca Pharma India Ltd. 2010.12.31 90

3. Aventis Pharma Ltd. 2010.12.31 60.4

4. Biocon Ltd. 2010.12.31 19.77

5. Fresenius Kabi Oncology Ltd. 2010.12.31 90

6. Fulford (India) Ltd. 2010.12.31 53.93

7. Glaxosmithkline Pharmaceuticals Ltd. 2010.12.31 50.67

8. K D L Biotech Ltd. 2010.12.31 23.47

9. Kerala Ayurveda Ltd. 2010.12.31 61.52

10. Matrix Laboratories Ltd. 2009.06.30 87.68

11. Merck Ltd. 2010.12.31 51.8

12. Novartis India Ltd. 2010.12.31 76.42

13. Pfizer Ltd. 2010.12.31 70.75

14. Ranbaxy Laboratories Ltd. 2010.12.31 63.82

15. Sandu Pharmaceuticals Ltd. 2010.12.31 24.21

16. Solvay Pharma India Ltd. 2010.12.31 88.85

17. Wanbury Ltd. 2010.12.31 20.59

18. Wyeth Ltd. 2010.12.31 51.12 (Source: CMIE-Prowess)

2. List of Non-FDI Companies

S.No Company Name Holding

Date Foreign

Promoter(%)

1. A B L Biotechnologies Ltd. 2010.12.31 0

2. Aarey Drugs & Pharmaceuticals Ltd. 2010.12.31 0

3. Aarti Drugs Ltd. 2010.12.31 0

4. Add-Life Pharma Ltd. 2006.03.31 0

5. Advik Laboratories Ltd. 2010.12.31 0

6. Ahlcon Parenterals (India) Ltd. 2010.12.31 0

7. Ajanta Pharma Ltd. 2010.12.31 0

8. Albert David Ltd. 2010.12.31 0

9. Alembic Ltd. 2010.12.31 0

10. Alpha Drug India Ltd. [Merged] 2005.12.31 0

11. Ambalal Sarabhai Enterprises Ltd. 2010.09.30 0

12. Amrutanjan Health Care Ltd. 2010.12.31 0

13. Ankur Drugs & Pharma Ltd. 2010.12.31 0

14. Anuh Pharma Ltd. 2010.12.31 0

15. Apte Amalgamations Ltd. 2010.12.31 0

16. Arvind Remedies Ltd. 2010.12.31 0

17. Auro Laboratories Ltd. 2010.12.31 0

18. Aurobindo Pharma Ltd. 2010.12.31 0

19. B D H Industries Ltd. 2010.12.31 0

20. Bafna Pharmaceuticals Ltd. 2010.12.31 0

21. Bal Pharma Ltd. 2010.12.31 0

22. Beryl Drugs Ltd. 2010.12.31 0

23. Bharat Immunologicals & Biologicals Corpn. Ltd. 2010.12.31 0

24. Biofil Chemicals & Pharmaceuticals Ltd. 2010.12.31 0

25. Brabourne Enterprises Ltd. [Merged] 2009.12.31 0

26. Cadila Healthcare Ltd. 2010.12.31 0

27. Caplin Point Laboratories Ltd. 2010.09.30 0

28. Chiplun Fine Chemicals Ltd. 2004.12.31 0

29. Cipla Ltd. 2010.12.31 0

30. Claris Lifesciences Ltd. 2010.12.31 0

31. Colinz Laboratories Ltd. 2010.12.31 0

32. Combat Drugs Ltd. 2010.12.31 0

33. Coral Laboratories Ltd. 2010.09.30 0

34. D I L Ltd. 2010.12.31 0

35. Desh Rakshak Aushdhalaya Ltd. 2010.12.31 0

36. Dolphin Laboratories Ltd. 2004.06.30 0

37. Dr. Reddy'S Laboratories Ltd. 2010.12.31 0

38. Dr. Sabharwal'S Manufacturing Labs Ltd. 2010.09.30 0

39. Dr. Wellmans Homoeopathic Laboratory Ltd. 2010.12.31 0

40. Dujohn Laboratories Ltd. 2010.09.30 0

41. Ebers Pharmaceuticals Ltd. 2001.09.30 0

42. Elder Health Care Ltd. 2010.12.31 0

43. Elder Pharmaceuticals Ltd. 2010.12.31 0

44. Emergy Phaarma Ltd. 2006.03.31 0

45. Eupharma Laboratories Ltd. 2004.09.30 0

46. Everest Organics Ltd. 2010.12.31 0

47. F D C Ltd. 2010.12.31 0

48. Gennex Laboratories Ltd. 2010.09.30 0

49. German Remedies Ltd. [Merged] 2003.06.30 0

50. Glenmark Pharmaceuticals Ltd. 2010.12.31 0

51. Godavari Drugs Ltd. 2010.09.30 0

52. Hester Biosciences Ltd. 2010.12.31 0

53. Hiran Orgochem Ltd. 2010.12.31 0

54. Ind-Swift Laboratories Ltd. 2010.09.30 0

55. Ind-Swift Ltd. 2010.12.31 0

56. Inwinex Pharmaceuticals Ltd. 2010.12.31 0

57. Ipca Laboratories Ltd. 2010.12.31 0

58. Ishita Drugs & Inds. Ltd. 2010.03.31 0

59. Ivee Injectaa Ltd. 2003.03.31 0

60. J B Chemicals & Pharmaceuticals Ltd. 2010.12.31 0

61. J K Pharmachem Ltd. 2005.06.30 0

62. Jagsonpal Pharmaceuticals Ltd. 2010.12.31 0

63. Jenburkt Pharmaceuticals Ltd. 2010.12.31 0

64. Kabra Drugs Ltd. 2010.12.31 0

65. Kamron Laboratories Ltd. 2010.12.31 0

66. Kappac Pharma Ltd. 2010.12.31 0

67. Kilitch Drugs (India) Ltd. 2010.12.31 0

68. Kopran Ltd. 2010.12.31 0

69. Krebs Biochemicals & Inds. Ltd. 2010.12.31 0

70. Laurel Organics Ltd. 2010.12.31 0

71. Lincoln Pharmaceuticals Ltd. 2010.12.31 0

72. Lupin Ltd. 2010.12.31 0

73. Lyka Labs Ltd. 2010.12.31 0

74. Makers Laboratories Ltd. 2010.12.31 0

75. Medi-Caps Ltd. 2010.12.31 0

76. Medicamen Biotech Ltd. 2010.12.31 1.94

77. Monozyme India Ltd. 2008.12.31 0

78. Morepen Laboratories Ltd. 2010.12.31 0

79. N G L Fine-Chem Ltd. 2010.12.31 0

80. Natco Pharma Ltd. 2010.12.31 0

81. National Diamond Jewellery House Ltd. 2010.12.31 0

82. Natural Capsules Ltd. 2010.12.31 0

83. Neuland Laboratories Ltd. 2010.12.31 2.47

84. Orchid Chemicals & Pharmaceuticals Ltd. 2010.12.31 0

85. Pan Drugs Ltd. 2010.12.31 0

86. Panacea Biotec Ltd. 2010.12.31 0

87. Panchsheel Organics Ltd. 2010.12.31 0

88. Parabolic Drugs Ltd. 2010.12.31 0

89. Parenteral Drugs (India) Ltd. 2010.12.31 0

90. Patidar Buildcon Ltd. 2010.12.31 0

91. Perk Pharmaceuticals Ltd. 2010.06.30 0

92. Phaarmasia Ltd. 2010.12.31 0

93. Pharmaids Pharmaceuticals Ltd. 2010.09.30 0

94. Piramal Healthcare Ltd. 2010.12.31 0

95. Plethico Pharmaceuticals Ltd. 2010.12.31 0

96. Poonam Pharmaceuticals Ltd. 2010.12.31 0

97. Principal Pharmaceuticals & Chemicals Ltd. 2010.12.31 0

98. Raymed Labs Ltd. 2010.12.31 0

99. Rekvina Laboratories Ltd. 2004.03.31 0

100. Relish Pharmaceuticals Ltd. 2010.06.30 0

101. Resonance Specialties Ltd. 2010.12.31 0

102. Roopa Industries Ltd. 2010.12.31 0

103. Rubra Medicaments Ltd. 2010.06.30 0

104. S S Organics Ltd. 2009.12.31 0

105. Samrat Pharmachem Ltd. 2010.12.31 0

106. Sanjivani Paranteral Ltd. 2010.12.31 0

107. Sarvodaya Labs Ltd. 2001.09.30 0

108. Senbo Industries Ltd. 2010.09.30 0

109. Sequent Scientific Ltd. 2010.12.31 0

110. Shaba Chemicals Ltd. 2010.12.31 0

111. Shasun Pharmaceuticals Ltd. 2010.12.31 0

112. Shilpa Medicare Ltd. 2010.12.31 0

113. Shrishma Fine Chemicals & Pharma. (Kar.) Ltd. 2004.06.30 0

114. Smithkline Beecham Pharmaceuticals (India) Ltd. 2001.09.30 0

115. Span Diagnostics Ltd. 2010.12.31 0

116. Sun Pharmaceutical Inds. Ltd. 2010.12.31 0

117. Supriya Pharmaceuticals Ltd. 2009.06.30 0

118. Surya Pharmaceutical Ltd. 2010.12.31 0

119. Suven Life Sciences Ltd. 2010.12.31 0

120. Sword & Shield Pharma Ltd. 2005.12.31 0

121. Syncom Formulations (India) Ltd. 2010.09.30 0

122. Syncom Healthcare Ltd. 2010.12.31 0

123. T T K Healthcare Ltd. 2010.12.31 0

124. Teem Laboratories Ltd. 2005.03.31 0

125. Themis Medicare Ltd. 2010.12.31 0

126. Toheal Pharmachem Ltd. 2010.09.30 0

127. Tonira Pharma Ltd. 2010.12.31 0

128. Torrent Pharmaceuticals Ltd. 2010.12.31 0

129. Trans Asia Corpn. Ltd. 2010.12.31 0

130. Trans Medicare Ltd. 2001.12.31 0

131. Transchem Ltd. 2010.12.31 0

132. Triochem Products Ltd. 2010.12.31 0

133. Twilight Litaka Pharma Ltd. 2010.12.31 0

134. Tyche Industries Ltd. 2009.03.31 0

135. Unichem Laboratories Ltd. 2010.12.31 0

136. Unjha Formulations Ltd. 2010.09.30 0

137. Vardhaman Laboratories Ltd. 2009.12.31 0

138. Venkat Pharma Ltd. 2010.12.31 0

139. Venmax Drugs & Pharmaceuticals Ltd. 2010.09.30 0

140. Venus Remedies Ltd. 2010.12.31 0

141. Veronica Laboratories Ltd. 2005.03.31 0

142. Vikram Thermo (India) Ltd. 2010.12.31 0

143. Vimta Labs Ltd. 2010.12.31 0

144. Vysali Pharmaceuticals Ltd. 2005.06.30 0

145. Welcure Drugs & Pharmaceuticals Ltd. 2010.12.31 0

146. Wintac Ltd. 2010.12.31 0

147. Wockhardt Ltd. 2010.12.31 0

148. Yogi Healthcare Ltd. 2006.03.31 0

149. Zenith Health Care Ltd. 2010.12.31 0

150. Zenotech Laboratories Ltd. 2010.09.30 2.01

151. Zillion Pharmachem Ltd. 2003.09.30 0

152. Zyden Gentec Ltd. 2010.12.31 0 (Source: CMIE-Prowess)

ANNEXURE II Select Financial Indicators

(The tables given below shows the information compiled and calculated from the data collected from CMIE-Prowess database)

1. Select Financial Indicators of Abbott India Ltd.(Rs Crores)

Year Foreign Promoter

quota (%)

Rs. Crores

FDI Forex earnings Sales Total

Export R&D Exp Profit Assets

Capital employed Networth

2000-01 51 8.262 6.12 382.43 3.25 2.28 86.87 227.83 97.7 95.32

2000-02 58.2 9.4284 4.12 406.21 1.81 2 72.77 236.28 131.55 129.17

2002-03 61.7 9.9954 6.09 425.58 1.58 2.09 84.25 272.02 169.42 167.07

2003-04 61.7 9.4278 3.17 446.78 2.07 1.48 97.93 272.22 148.7 146.5

2004-05 61.7 9.4278 3.58 474.01 2.76 1.45 138.22 313.3 190.47 188.28

2005-06 61.7 9.4278 3.53 471.69 3.36 1.51 87.12 311.68 218.26 216.44

2006-07 65.14 9.9534 3.54 542.62 3.24 2.08 87.43 341.82 247.22 245.81

2007-08 65.14 9.4258 3.93 639.27 3.49 3.55 101.88 364.74 232.05 231.02

2008-09 68.94 9.431 7.33 707.28 4.37 5.02 95.38 388.53 222.01 221.25

2009-10 68.94 9.431 8.56 801.72 4.4 6.04 117.19 424.27 271.56 271.56 (Source:CMIE-Prowess)

2. Select Financial Indicators of Astrazeneca Pharma India Ltd.


quota (%)

Rs. Crores


Export R&D

Expenses Profit Assets Capital employed Networth

2000-01 51.5 2.575 0.19 109.15 0.18 4.61 20.15 88.27 66.08 66.71

2000-02 56.5 2.825 0.03 95.89 0 4.61 6.88 93.62 67.14 67.47

2002-03 91.61 4.5805 1.45 153.2 1.45 2.77 19.5 120.34 75.92 75.98

2003-04 91.61 4.5805 2.19 196.11 2.19 2.56 38.48 145.89 98.05 98.05

2004-05 90 4.5 3.6 210.89 3.6 2.7 44.78 167.44 95.54 95.54

2005-06 90 4.5 3.73 246.42 3.73 2.17 65.99 178.79 127.19 127.19

2006-07 90 4.5 6.24 293.68 6.24 2.58 74.95 243.06 141.72 141.72

2007-08 90 4.5 8.84 330.51 8.84 2.46 95.35 411.98 159.31 159.31

2008-09 90 4.5 24.12 374.38 22.88 2.45 119.25 291.27 178.65 116.15

2009-10 90 4.5 28.66 405.04 28.66 2.3 88.53 235.92 144.52 144.52 (Source:CMIE-Prowess)

3. Select Financial Indicators of Aventis Pharma Ltd


quota(%)

Rs. Crores


Export R&D


2000-01 50.1 11.53803 60 559.16 60 1.52 50.76 369.15 188.41 197.23

2000-02 50.1 11.53803 104.26 598.03 102.82 2.99 96.5 416.37 246.12 246.39

2002-03 50.1 11.53803 128.91 669.14 127.96 4.59 91.09 436.96 269.67 269.15

2003-04 50.1 11.53803 153.28 709.68 149.2 3.99 146.61 487.24 317.93 321.33

2004-05 50.1 11.53803 213.26 793.56 200.98 4.02 226.3 589.87 404.03 421.84

2005-06 50.1 11.53803 242.54 868.47 222.2 3.34 225.04 710.45 506.82 523.79

2006-07 50.12 11.542636 235.94 951.81 220.82 3.26 249.89 872.28 592.07 608.21

2007-08 50.12 11.542636 184.56 961.13 166.76 4.53 221.97 930.77 691.55 706.85

2008-09 50.12 11.542636 229.09 1070.38 205.49 5.01 259.89 1078.22 814.64 829.1


4. Select Financial Indicators of Biocon Ltd


quota(%)

Rs. Crores


Export R&D


2000-01 0 0 27.37 123.57 27.37 3.87 30.65 133.76 89.84 66.99

2000-02 0 0 47.41 162.03 47.41 7.55 32.33 213.6 121.42 87.7

2002-03 0 0 108.52 276.98 108.34 11.42 52.3 276.92 165.71 126.71

2003-04 0 0 300.57 535.94 300.44 23.33 149.61 753.5 583.54 541.63

2004-05 24.9 12.45 378.04 688.43 376.23 24.09 190.36 1024.27 770.71 695.94

2005-06 20.47 10.235 358.95 725.75 358.8 40.08 162.52 1160.23 904.24 803.05

2006-07 20.47 10.235 476.34 888.77 476.16 47.87 183.54 1307.5 1001.47 941.64

2007-08 20.47 10.235 522.62 905.07 522.47 64.65 447.75 1750.4 1468.78 1328.2

2008-09 20.47 20.47 471.78 938.8 471.78 74.38 126.14 1880.57 1512.73 1374.88


5. Select Financial Indicators of Fresenius Kabi Oncology Ltd


quota(%)

Rs. Crores


Export R&D

Expenses Profit Assets Capital

employed Networth

2000-01 0 0 NA NA 0 NA NA NA NA NA



2003-04 0 0 79.34 215.45 79.1 18.16 19.06 238.86 191.52 198.6

2004-05 0 0 104.41 235.76 104.39 21.5 29.14 311.57 223.74 224.16

2005-06 0 0 118.22 270.44 116.75 26.89 24.6 409.14 302.81 309.35

2006-07 0.03 0.004701 171.65 312.7 166.66 35.71 35.76 552.34 386.31 334.89

2007-08 0.03 0.004701 184.58 250.3 175.58 26.23 162.83 803.11 543.56 499.15

2008-09 90 14.238 195.66 274.09 184.6 30.73 -56.23 782.21 563.51 411.86

2009-10 90 14.238 360.95 432.51 355.94 34.7 102.93 920.06 631.94 492.09 (Source:CMIE-Prowess)

6. Select Financial Indicators of Fulford (India) Ltd


quota(%)

Rs. Crores


Export R&D


employed Networth

2000-01 40 1.28 0 134.49 0 0 2.59 62.08 22.74 13.95

2000-02 40 1.28 0 140.41 0 0 4.18 51.12 26.5 15.49

2002-03 40 1.28 0.29 94.7 0 0 -5.49 36.14 20.01 7.88

2003-04 40 1.28 0.14 130.51 0.14 0 8.51 42.58 20.38 13.31

2004-05 40 1.28 0 131.79 0 0 20.2 41.77 25.4 24.36

2005-06 40 1.28 0.1 151.97 0.1 0 24.46 59.18 38.33 38.31

2006-07 50.77 1.98003 0.38 155.04 0.38 0 19.97 108.53 89.9 89.9

2007-08 53.93 2.10327 0.5 174.38 0.5 0 33.91 134.3 109.62 109.62

2008-09 53.93 2.10327 0.31 190.44 0.31 0 31.57 226.8 128.43 128.43

2009-10 53.93 2.10327 0 195.28 0 0 22.09 241.06 139.84 139.84 (Source:CMIE-Prowess)

7. Select Financial Indicators of Glaxosmithkline Pharmaceuticals Ltd


quota(%)

Rs. Crores


Export R&D


employed Networth

2000-01 51 30.4878 74.29 952.01 72.26 4.14 114.15 600.31 410.93 394.46

2000-02 48.83 36.368584 78.44 1120.17 75.72 3.97 104.29 786.47 569.61 560.58

2002-03 48.83 36.368584 66.78 1167.89 66.78 3.88 172.55 1441.83 581.26 579.28

2003-04 48.83 36.368584 41.06 1209.5 39.11 3.54 276.82 1646.72 670.35 667.49

2004-05 49.15 42.91778 38.62 1490.89 37.38 4.51 487.16 2330 928.1 924.26

2005-06 50.67 42.91749 46.02 1593.86 44.6 4.39 674.12 2581.26 953.45 948.6

2006-07 50.67 42.91749 59.32 1710.82 55.57 6.15 740.38 3035.84 1200.26 1194.72

2007-08 50.67 42.91749 83.73 1761.39 79.13 5.81 748.23 3516.28 1366.69 1360.92

2008-09 50.67 42.91749 96.28 1796.22 94.65 12.68 808.64 4019.45 1546.74 1541.09


8. Select Financial Indicators of K D L Biotech Ltd.


quota(%)

Rs. Crores


Export R&D


employed Networth

2000-01 25.87 4.335812 101.38 159.45 101.38 0 14.41 188.76 107.47 79.21

2000-02 25.87 4.335812 100.79 170.95 100.79 0 15.46 213.51 123.51 89.21

2002-03 25.87 4.335812 114.12 168.94 114.12 0 11.9 226.69 116.73 91.58

2003-04 33.65 5.63974 83.55 132 83.55 0 5.5 210.28 115.63 88.58

2004-05 33.65 0 - - 0 - - - - -

2005-06 33.65 5.63974 29.82 120.48 29.82 0 -12.1 163.07 65.33 34

2006-07 0 0 - - 0 - - - - -

2007-08 33.65 5.63974 31.36 118.17 31.36 0 -0.34 168.26 22.98 7.43

2008-09 23.47 5.642188 8.99 60.04 8.99 0 -11.34 133.64 67.79 39.37

2009-10 23.47 5.642188 0.68 26.42 0.68 0 -9.35 120.4 50.78 22.37 (Source:CMIE-Prowess)

9. Select Financial Indicators of Kerala Ayurveda Ltd.


quota(%)

Rs. Crores


Export R&D


employed Networth

2000-01 2.61 0.1566 1.01 11.59 1.01 0.07 1.29 20.95 14.6 8.18

2000-02 6.49 0.419254 1.28 12.59 1.28 0.06 -0.47 21.74 15.06 6.05

2002-03 6.49 0.419254 0 13.26 0 0.08 0.46 21.72 14.42 4.42

2003-04 6.49 0.419254 0.81 11.59 0.81 0.07 1.2 16.67 9.49 4.8

2004-05 6.49 0.419254 1.28 11.29 1.28 0.12 0.89 17.95 9.65 4.81

2005-06 52.85 3.99546 1.07 10.81 1.07 0.08 0.36 29.48 19.96 8.16

2006-07 61.52 6.496512 0.84 16.41 0.84 0.14 -0.41 43.95 37.59 20.36

2007-08 61.52 6.496512 3.21 18.59 3.21 0.14 -4.36 56.66 44.06 15.73

2008-09 61.52 6.496512 1.04 19 0.99 0.1 -3.01 58.69 46.42 11.65

2009-10 61.52 6.496512 0.71 21.07 0.66 0.07 -0.81 66.09 49.03 10.01 (Source:CMIE-Prowess)

10. Select Financial Indicators of Matrix Laboratories Ltd


quota(%)

Rs. Crores


Export R&D


employed Networth

2000-01 0 0 4.56 67.89 4.56 0.31 5.99 42.41 20.44 13.8

2000-02 0 0 9.61 103.89 9.61 1.73 8.43 69.05 36.94 21.52

2002-03 0 0 281.98 416.93 281.63 5.42 122.24 327 206.18 101.58

2003-04 0 0 297.59 557.41 297.59 16.3 166.18 556.81 282.86 178.2

2004-05 39.15 11.72151 340.42 664.23 336.6 27.2 167.28 995.58 631.54 624.01

2005-06 38.14 11.716608 417.11 788.48 390.27 59.9 219.87 1409.74 873.87 869.44

2006-07 71.39 22.002398 526.27 775.43 499.43 92.1 126.41 1602.04 982.48 978.54

2007-08 71.18 22.008856 639.31 974.27 612.4 119.71 -236.71 1561.94 747.51 687.91

2008-09 76.13 23.539396 1243.07 1504.41 1224.24 221.44 312.88 2102.15 1025.55 877.59

2009-10 0 0 1539.37 1894.3 1537.25 265.87 350.73 2686.78 1354.17 1152.2 (Source:CMIE-Prowess)

11. Select Financial Indicators of Merck Ltd.


quota(%)

Rs. Crores


Export R&D


employed Networth

2000-01 51 8.5986 17.81 315.95 17.37 0.64 55.84 190.99 131.82 131.82

2000-02 51 8.5986 15.92 341.65 12.94 0.71 64.6 216.48 147.09 150.49

2002-03 51 8.5986 14.73 385.56 13.03 0.37 61.73 247.54 162.02 175.63

2003-04 51 8.5986 21.29 404.06 18.64 0.14 68.47 278.05 196.25 196.25

2004-05 51 8.5986 16.22 418.39 14.36 0.3 106.97 326.99 248.18 248.18

2005-06 51 8.5986 18.8 438.09 16.14 1.61 116.96 386.52 298.13 298.13

2006-07 51 8.5986 19.18 371.66 17.55 1.56 167.21 479.36 393.03 393.03

2007-08 51 8.5986 20.58 357.65 19.78 1.48 99.87 490.58 422.9 422.9

2008-09 51 8.5986 30.74 424.69 30.01 1.56 91.75 563.9 451.39 451.39


12. Select Financial Indicators of Novartis India Ltd


quota(%)

Rs. Crores


Export R&D


employed Networth

2000-01 50.99 8.148202 14.77 457.74 13.77 1.64 80.71 383.12 236.1 167.29

2000-02 50.93 8.138614 5.59 481.72 5.56 0.6 98.53 350.83 211.92 208.62

2002-03 50.93 8.138614 6.52 488.29 5.42 1.01 92.4 380.24 246.8 243.58

2003-04 50.93 8.138614 8.56 523.1 7.85 0.95 144.17 377.6 259.85 255.79

2004-05 50.93 8.138614 10.3 490.09 9.31 0.69 102.69 414.08 288.29 284.38

2005-06 50.93 8.138614 6.06 543.75 3.79 1.62 153.45 479.12 341.5 337.6

2006-07 50.93 8.138614 7.06 563.9 3.8 0.84 138.99 491.46 393.28 388.58

2007-08 50.93 8.138614 9.17 578.67 4.21 0.76 152.51 584.23 448.86 448.42

2008-09 50.93 8.138614 9.1 625.09 6.78 0.31 168.98 672.02 515.04 514.74


13. Select Financial Indicators of Pfizer Ltd.


quota(%)

Rs. Crores


Export R&D


employed Networth

2000-01 40 9.372 19.42 374.49 14.25 14.23 65.02 226.49 130.6 135.3

2000-02 40 9.376 19.74 410.33 19.7 13.21 79.06 280.03 169.89 169.89

2002-03 40 9.376 58.24 696.74 22.33 18.58 131.6 473.17 255.84 308.03

2003-04 40 11.52 27.08 588.4 27.08 21.19 44.15 448.47 254.36 308.4

2004-05 40 11.52 24.06 684.83 24.06 23.51 75.65 529.56 294.69 342.76

2005-06 41.23 12.303032 26.97 724.15 26.97 22.36 109.12 580.23 339.86 376.56

2006-07 41.23 12.303032 28.54 791.98 28.54 23.8 162.08 1134.93 392.39 405.73

2007-08 41.23 12.303032 22.07 794.27 22.07 24.58 450.14 1471.06 645.72 648.65

2008-09 41.23 12.303032 22.98 786.73 22.98 28.35 418.56 1825.88 899.56 899.56


14. Select Financial Indicators of Ranbaxy Laboratories Ltd.


quota(%)

Rs. Crores


Export R&D


employed Networth

2000-01 0 0 791.29 1775.71 752.94 73.39 256.18 2388.87 1501.22 1582.65

2000-02 0 0 1085.52 1959.78 1045.21 77.12 335.71 2520.94 1466.55 1606.98

2002-03 0 0 2015.62 3131.76 1901.92 192.17 589.05 2860.48 1879.7 1873.46

2003-04 0 0 2559.14 3888.98 2447.66 276.13 964.44 3659.95 2323.55 2321.78

2004-05 0 0 2513.96 3865.87 2404.83 399.66 638.37 4236.57 2509.24 2509.51

2005-06 0 0 2357.75 3284.03 2254.84 639.33 221.11 4848.3 2540.46 2377.31

2006-07 0 0 2755.86 3599.15 2622.76 483.82 549.15 7096.87 4542.28 2350.01

2007-08 0 0 2660.86 3656.2 2530.18 460.51 947.58 7956.92 4820.44 2538.41

2008-09 63.92 134.353448 2853.79 3973.41 2699.96 471.38 -1469.21 12013.5 6371.88 3541.13

2009-10 63.9 134.32419 3136.45 4653.37 2799.48 494.38 1450.47 11605 6663.62 3958.96 (Source:CMIE-Prowess)

15. Select Financial Indicators of Sandu Pharmaceuticals Ltd.


quota(%)

Rs. Crores


Export R&D Expenses Profit Assets Capital

employed Networth

2000-01 27.03 1.913724 0 5 0 0 0.92 11.62 9.28 9.07

2000-02 27.03 1.913724 0 5.49 0 0 0.99 12 9.25 9.29

2002-03 27.03 1.913724 0 6.35 0 0 1.05 12.77 9.74 9.85

2003-04 27.03 1.913724 0 8.08 0 0 1.12 13.94 10.41 10.49

2004-05 27.03 1.913724 0 8.3 0 0 1.11 15.04 11.12 11.19

2005-06 27.03 1.913724 0 10.03 0 0 1.39 15.63 12.18 12.23

2006-07 0 0 0 11.97 0 0 1.48 16.88 13.27 13.35

2007-08 0 0 0 13.47 0 0 1.11 18.01 14.01 14.07

2008-09 0 0 0 14.26 0 0 1.28 19.73 14.9 14.93


16. Select Financial Indicators of Solvay Pharma India Ltd.


quota(%)

Rs. Crores


Export R&D


employed Networth

2000-01 0 0 0.08 74 0.07 0 12.71 18.98 12.96 12.96

2000-02 63.94 3.22897 0.12 85.66 0.11 0 13.12 31.41 20.02 20.02

2002-03 63.94 3.22897 0 91.48 0 0 16.25 47.53 26.44 26.44

2003-04 63.94 3.22897 0 106.94 0 0 12.73 54.47 33.04 32.67

2004-05 63.94 3.22897 0 127.73 0 0 33.09 71.25 53.45 53.18

2005-06 68.85 3.476925 0 141.91 0 0 28.45 89.37 68.1 67.94

2006-07 68.85 3.476925 0 157.49 0 0 29.61 108.43 82.1 82.06

2007-08 68.85 3.476925 0 183.18 0 0 42.82 118.77 86.8 86.8

2008-09 68.85 3.476925 0 212.88 0 0 50.2 157.2 109.27 109.27


17. Select Financial Indicators of Wanbury Ltd.


quota(%)

Rs. Crores


Export R&D


employed Networth

2000-01 0 0 0.69 10.43 0.69 0 2.22 21.68 17.64 4.75

2000-02 0 0 8.62 16.55 8.62 0 3.12 25.19 18 5.16

2002-03 0 0 15.44 25.14 15.44 0 3.57 31.01 17.69 9.83

2003-04 0 0 23.33 55.15 23.33 0 4.58 92.13 28.91 53.27

2004-05 31.88 3.025412 27.31 76.29 27.31 6.25 10.93 112.48 37.01 55.1

2005-06 23.72 3.0243 59.41 115.71 58.85 12.72 18.58 196.21 103.13 101.15

2006-07 23.72 3.0243 76.76 153.57 76.7 4.07 22.79 329.69 183.25 129.13

2007-08 20.59 NA NA NA 0 NA NA NA NA NA

2008-09 20.59 3.024671 175.02 351.2 175 2.05 -39.6 569.22 336.45 116.61


18. Select Financial Indicators of Wyeth Ltd


quota(%)

Rs. Crores


Export R&D


employed Networth

2000-01 50.37 9.943038 28.11 297.01 28.11 1.16 52.22 212.98 151.33 152.01

2000-02 50.37 9.943038 36.24 307.88 36.2 1.06 63.94 240.23 183.75 182.38

2002-03 50.37 9.338598 25.33 335.77 25.04 1.68 49.22 286.03 224.57 222.07

2003-04 51.12 11.614464 23.64 351.88 23.64 0.54 74.19 331.03 257.85 255.35

2004-05 51.12 11.614464 0.09 289.92 0.09 0.29 40.73 365.66 244.98 242.48

2005-06 51.12 11.614464 0.23 315.74 0.23 0.51 83.13 357.18 247.93 245.43

2006-07 51.12 11.614464 1.26 318.62 1.26 0.59 111.39 384.21 259.17 256.67

2007-08 51.12 11.614464 7.62 361.89 7.05 0.79 118.15 395.77 260.9 258.4

2008-09 51.12 11.614464 0.88 402.19 0.84 0.97 142.75 434.4 274.18 271.68


19. Trends of FDI Inflows in Select Indian Pharmaceutical firms

FDI Inflows (Rs.Crores) S.No

Name of the company 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 1.

Abbott India Ltd. 8.262 9.428 9.995 9.428 9.428 9.428 9.953 9.426 9.431 9.431 2.

Astrazeneca Pharma India Ltd. 2.575 2.825 4.581 4.581 4.5 4.5 4.5 4.5 4.5 4.5 3.

Aventis Pharma Ltd. 11.538 11.538 11.538 11.538 11.538 11.538 11.543 11.543 11.543 13.910 4.

Biocon Ltd. 0 0 0 0 12.45 10.235 10.235 10.235 20.47 20.47 5.

Fresenius Kabi Oncology Ltd. 0 0 0 0 0 0 0.005 0.005 14.238 14.238 6.

Fulford (India) Ltd. 1.28 1.28 1.28 1.28 1.28 1.28 1.980 2.103 2.103 2.103 7.

Glaxosmithkline Pharmaceuticals Ltd. 30.488 36.369 36.369 36.369 42.918 42.917 42.917 42.917 42.917 42.917 8.

Kerala Ayurveda Ltd. 4.336 4.336 4.336 5.640 0.000 5.640 0.000 5.640 5.642 5.642 9.

K D L Biotech Ltd. 0.157 0.419 0.419 0.419 0.419 3.995 6.497 6.497 6.497 6.497 10.

Matrix Laboratories Ltd. 0 0 0 0 11.722 11.717 22.002 22.009 23.539 0 11.

Merck Ltd. 8.599 8.599 8.599 8.599 8.599 8.599 8.599 8.599 8.599 8.599 12.

Novartis India Ltd. 8.148 8.139 8.139 8.139 8.139 8.139 8.139 8.139 8.139 12.212 13.

Pfizer Ltd. 9.372 9.376 9.376 11.52 11.52 12.303 12.303 12.303 12.303 21.112 14.

Ranbaxy Laboratories Ltd. 0 0 0 0 0 0 0 0 134.353 134.324 15.

Sandu Pharmaceuticals Ltd. 1.914 1.914 1.914 1.914 1.914 1.914 0 0 0 1.9137 16.

Solvay Pharma India Ltd. 0 3.229 3.229 3.229 3.229 3.477 3.477 3.477 3.477 3.477 17.

Wanbury Ltd. 0 0 0 0 3.025 3.024 3.024 NA 3.0247 3.0247 18.

Wyeth Ltd 9.943 9.943 9.339 11.614 11.614 11.614 11.614 11.614 11.614 11.614 (Source:CMIE-Prowess)

20. Aggregates of select FDI based Pharmaceutical companies with Foreign Promoters quota and FDI(Aggregates)

(Source:CMIE-Prowess)

Years % of FDI

Rs. Crores

FDI Forex earnings Sales R & D exp. Profit Assets Networth Capital employed

2000-01 28.91 96.61 1160.16 5811.59 107.99 854.38 5196.99 3130.06 3211.7

2000-02 33.49 107.39 1521.5 6420.28 115.65 999.45 5787.37 3572.42 3564.73

2002-03 35.76 109.11 2847.45 8549.09 244.06 1490.65 7506.25 4284.31 4437.81

2003-04 34.24 114.27 3626.44 10072.7 368.38 2222.79 9633.6 5681.41 5795.22

2004-05 39.50 142.29 3676.95 10663.29 516.29 2313.81 11870.4 6935.96 6955.67

2005-06 41.75 150.32 3698.39 10822.82 816.51 2219.04 13974.31 7703.28 7970.15

2006-07 41.50 156.79 4371.9 11616.71 704.57 2689.65 18157.59 8582.24 10945.68

2007-08 43.36 159.01 4383.96 12079.43 715.2 3381.59 20746.02 9530.8 12092.75

2008-09 51.83 322.39 5372 13727.31 856.43 1044.96 27231.06 11482.54 15091

2009-10 52.77 315.99 6208.79 15745 938.3 4138.48 28874.15 13122.54 16536.67

21. Select Financial Indictors of Non-FDI based Companies ( Aggregates)


Year

Rs. Crores

Sales R & D expenses Profit Net worth Total assets Net fixed assets Net working capital

2000-01 21378.59 501.77 3777.46 11160.08 24328.93 8952.17 3542.14

2000-02 24333.08 642.29 4627.18 12769.05 27721.82 9879.78 4960.12

2002-03 28340.33 859.88 5474.19 14727.79 32817.53 11456.1 5920.68

2003-04 32679.87 1335.14 6566.74 17501.81 38542.88 13207.4 5888.72

2004-05 34514.51 1888.43 6922.1 20546.04 47677.59 15980.45 7815.85

2005-06 39751.15 2423.81 8316.78 25086.7 58129.42 19009.7 9337.25

2006-07 48517.02 2737.43 11906.28 34393.57 71940.06 22486.95 14764.99

2007-08 55758.68 3096.56 13699.4 42170.08 86359.88 26512.11 13726.45

2008-09 63886.51 3442.96 10949.61 48333.02 107088.4 30852.73 14464.48

2009-10 71179.84 3598.05 17332.26 59542.71 118624.1 34215.45 19565.41

22. Number of FDI-based Companies with Foreign Promoters Quota


Number of FDI-based Companies with Foreign Promoters Quota

Foreign promoter (%)

2001 % of total

2002 % of total

2003 % of total

2004 % of total

2005 % of total

2006 % of total

2007 % of total

2008 % of total

2009 % of total

2010 % of total

0-20

7

38.9 6

33.3 6 33.3 6 33.3 3 16.7 2 11.1 4 22.2 3 16.7 1 5.5 1 5.5

21-40

4

22.2 4

22.2 4 22.2 4 22.2 8 44.4 6 33.3 2 11.1 3 16.7 3 16.7 4 22.2

41-60

7

38.9 7

38.9 5 27.9 5 27.9 4 22.2 7 38.9 7 38.9 7 38.9 7 38.9 4 22.2

61-80

-

- 1

5.5 2 11.1 2 11.1 2 11.1 2 11.1 4 22.2 4 22.2 5 27.8 7 38.9

81-100 - - -

- 1 5.5 1 5.5 1 5.5 1 5.5 1 5.5 1 5.5 2 11.1 2 11.1

Total no. of companies

18 100 18 100 18 100 18 100 18 100 18 100 18 100 18 100 18 100 18 100

ANNEXURE-III

FDI Policy 2006

Sector specific policy for FDI : In the following sectors/activities, FDI upto

the limit indicated below is allowed subject to other conditions as indicated:

S.No. Sector/Activity FDI Cap /

Equity

Entry

Route

Other conditions Relevant

Press Note

issued by

DIPP, GOI

1. Airports-

a. Greenfield projects 100% Automatic Subject to sectoral regulations notified by

Ministry of Civil Aviation www.civilaviation.nic. in

PN 4 / 2006

b. Existing projects 100% FIPB

Beyond 74%

Subject to sectoral regulations notified by

Ministry of Civil Aviation

www.civilaviation.nic. in

PN 4 / 2006

2. Air Transport

Services

49%- FDI;

100%for NRI

investment

Automatic Subject to no direct or indirect participation by

foreign airlines. Government of India Gazette

Notification dated 2.11.2004 issued by Ministry of

Civil Aviation www.civilaviation.nic. in

PN 4 / 2006

3. Alcohol-

Distillation &

Brewing

100%

Automatic

Subject to license by appropriate

authority

PN 4 / 2006

4. Asse t

Reconstruction

Companies

49%

(only

FDI)

FIPB Where any individual investment exceeds 10% of

the equity, provisions of Section 3(3)(f) of

Securitization and Reconstruction of Financial

Assets and Enforcement of Security Interest

Act, 2002 should be complied with.

www.finmin.nic.in

5. Atomic Minerals 74% FIPB Subject to guidelines issued by Department of

Atomic Energy vide Resolution No. 8/1(1)/97-

PSU/1422 dated 6.10.98.

6. Banking - Private

sector

74%

(FDI+FII)

Automatic Subject to guidelines for setting up branches /

subsidiaries of foreign banks issued by RBI.

www.rbi.org.in

PN 2 / 2004

7. Broadcasting

a. FM Radio FDI +FII

investment

up to 20%

FIPB Subject to Guidelines notified by Ministry of

Information & Broadcasting www.mib.nic.in

PN 6 / 2005

b. Cable network 49%

(FDI+FII)

FIPB Subject to Cable Television Network Rules (1994)

Notified by Ministry of Information &

Broadcasting www.mib.nic.in

c. Direct-To-Home 49%

(FDI+FII).

Within this

limit, FDI

component

not to exceed

20%

FIPB Subject to guidelines issued by

Ministry of Information &


d. Setting up hardware

facilities such as up-

linking, HUB, etc

49%

(FDI+FII)

FIPB Subject to Up-linking Policy notified by Ministry

of Information & Broadcasting www.mib.nic.in

PN 1 / 2006

e. Up-linking a News

& Current Affairs

TV Channel

26%

FDI+FII

FIPB Subject to guidelines issued by



PN 1/ 2006

f. Up-linking a Non- news &

Current Affairs TV

Channel

100% FIPB Subject to guidelines issued by


Broadcasting

www.mib.nic.in

PN 1 / 2006

8. Cigars &

Cigarettes-

Manufacture

100% FIPB Subject to industrial license under the Industries

(Development & Regulation) Act, 1951

PN 4 / 2006

9. Coal & Lignite mining for

captive consumption by

power projects, and iron &

steel, cement production

and other eligible activities

permitted under the Coal

Mines (Nationalisation) Act,

1973.

100% Automatic Subject to provisions of Coal Mines

(Nationalization) Act, 1973 www.coal.nic.in

PN 4 / 2006

10. Coffee & Rubber

processing &

warehousing

100% Automatic PN 4 / 2006

11. Construction

Development projects,

including housing,

commercial premises,

resorts, educational

institutions, recreational

facilities, city

and regional

level infrastructure,

townships.

100% Automatic Subject to conditions notified vide Press Note 2

(2005 Series) including:

a. minimum capitalization of US$ 10 million for

wholly owned subsidiaries and US$ 5 million

for joint venture. The funds would have to be

brought within six months of commencement

of business of the Company.

b. Minimum area to bedeveloped under

eachproject- 10 hectares in case of

development of serviced housing plots; and

built-up area of 50,000 sq. mts. in case of

construction development project; and any

of the above in case of a combination

project.

[Note: For investment by NRIs, the conditions mentioned in Press Note 2 / 2005 are not applicable.]

PN 2 /

2005 &

PN 2/

2006

12. Courier services for

carrying packages, parcels

and other items which do

not come within the ambit

of the Indian Post Office

Act, 1898.

100% FIPB Subject to existing laws and exclusion of

activity relating to distribution of letters,

which is exclusively reserved for the

State. www.indiapost.gov.in

PN 4 / 2001

13. Defence

production

26% FIPB Subject to licensing under Industries

(Development & Regulation) Act, 1951 and

guidelines on FDI in production of arms &

ammunition.

PN 4 /

2001 & PN

2 / 2002

Drugs &

Pharmaceutical

100% Automatic

14. Floriculture, Horticulture,

Development of Seeds,

Animal Husbandry,

Pisciculture, aqua-

culture, cultivation of

vegetables,

mushrooms, under

controlled conditions and

services related to agro

and allied sectors.

100% Automatic PN 4 / 2006

15. Hazardous chemicals,

viz., hydrocyanic acid and

its derivatives; phosgene

and its derivatives; and

isocyanates and

diisocyantes of

hydrocarbon.

100% Automatic Subject to industrial license under

the Industries (Development & Regulation)

Act, 1951 and other sectoral regulations.

PN 4 / 2006

16. Industrial

explosives -

Manufacture

100% Automatic Subject to industrial license under Industries

(Development & Regulation) Act, 1951 and

regulations under Explosives Act, 1898

PN 4 / 2006

17. Insurance 26% Automatic Subject to licensing by the Insurance

Regulatory & Development Authority

www.irda.nic.in

PN 10 / 2000

18. Investing companies in

infrastructure/services

sector (except telecom

sector)

49% FIPB Foreign investment in an investing co. will not be

counted towards sectoral cap in

infrastructure/services sector provided the

investment is up to 49% and the management

of the company is in Indian hands

PN 2 /

2000 & PN

5 / 2005

19. Mining covering

exploration and mining of

diamonds

& precious stones; gold,

silver and minerals.

100% Automatic Subject to Mines & Minerals (Dev. &

Regulation) Act, 1957

Press Note 18 (1998) and Press Note 1 (2005)

are not applicable for setting up 100% owned

subsidiaries in so far as the mining sector is

concerned, subject to a declaration from the

applicant that he has no existing joint venture

for the same area and /or the particular

mineral.

PN 2 / 2000,

PN 3 /

2005, & PN

4 / 2006

20. Non Banking Finance Companies- approved activities

i

ii)

iii)

iv)

v)

vi)

vii)

viii)

ix)

x)

xi)

xii)

xiii)

xiv)

xv)

xvi)

xvii)

xviii)

xix)

Merchant banking

Underwriting

Portfolio Management

Services

Investment Advisory

Services

Financial Consultancy

Stock Broking

A ss e t Management

Venture Capital

Custodial Services

Factoring

Credit

referAgencies

Creditr ating

Agencies

Leasing&Finance

Housing Finance

Forex Broking

Credit card business

Money changing

business

Micro credit

Rural credit.

100% Automatic Subject to:

a. minimum capitalization norms for fund based

NBFCs - US$ 0.5 million to be brought

upfront for FDI up to 51%; US$ 5 million to

be brought upfront for FDI above 51% and

up to 75%; and US$ 50 million out of which

US$ 7.5 million to be brought upfront and

the balance in 24 months forFDI beyond 75%

and upto 100%.

b. minimum capitalization norms for non-fund

based NBFC activities-US$ 0.5 million.

c. foreign investors can set up 100% operating

subsidiaries without the condition to

disinvest a minimum of 25% of its equity to

Indianentities subject to bringing inUS$ 50

million without any restriction on number of

operating subsidiaries without bringing

additional capital.

d. joint venture operating

NBFC’s that have 75% or less than 75%

foreign investment will also be allowed to set

up subsidiaries for undertaking other NBFC

activities subject to the subsidiaries also

complying with the applicable minimum

capital inflow.

e. compliance with the

guidelines of the RBI.

PN 2 / 2000,

PN 6 /

2000, & PN

2 / 2001

21. Petroleum & Natural Gas sector

a. Other than Refining

and including market

study and

formulation;

investment/

financing; setting up

infrastructure for

marketing in

Petroleum & Natural

Gas sector.

100% Automatic Subject to sectoral regulations issued by

Ministry of Petroleum & Natural Gas; and

in the case of actual trading and mktg. of

petroleum products, divestment of 26%

equity in favour of Indian partner / public

within 5 years. www.petroleum.nic.in

PN 1 /

2004 & PN

4 / 2006

b. Refining 26% in

case of

PSUs

100% in

case of

Private

companies

FIPB

(in case of

PSUs)

Automatic (in

case of

private

companies)

Subject to Sectoral policy

www.petroleum.nic.in

PN 2 / 2000

22. Print Media

a. Publishing of

newspaper &

periodicals

dealing with news

and current

affairs

26% FIPB Subject to Guidelines notified by Ministry of

Information & Broadcasting. www.mib.nic.in

b. Publishing of

scientific

magazines

/specialty

journals/

periodicals

100% FIPB Subject to guidelines issued by Ministry of

Information & Broadcasting.

www.mib.nic.in

PN 1 / 2004

23. Power including

generation (except

Atomic energy);

transmission,

distribution and

Power Trading.

100% Automatic Subject provisions of the Electricity Act, 2003

www.powermin.nic.in

PN 2 / 1998,

PN 7/2000

& PN

4/2006

24. Tea Sector,

including tea

plantation

100% FIPB Subject to divestment of 26% equity in favour of

Indian partner/Indian public within 5 years and

prior approval of State

Government for change in land use.

PN 6 / 2002

25. Telecommunications

a. Basic and cellular,

Unified Access

Services, National/

International

Long Distance, V-

Sat, Public Mobile

Radio Trunked

Services (PMRTS),

Global Mobile

Personal

Communications

Services (GMPCS)

and other value

added telecom

services

74% Automatic

up to 49%.

FIPB

beyond

49%.

Subject to guidelines notified in the PN 5 (2005

Series).

PN 5 / 2005

b. ISP with gateways,

radio- paging, end-to-

end bandwidth.

74% Automatic

up to 49%.

FIPB

beyond

49%.

Subject to licensing and security requirements

notified by the Department of

Telecommunications. www.dotindia.com

PN 4 / 2001

c. ISP without gateway,

infrastructure

provider providing

dark fibre, electronic

mail and voice mail

100% Automatic

up to 49%.

FIPB

beyond

49%.

Subject to the condition that such companies

shall divest 26% of their equity

in favour of Indian public in

5 years, if these companies are listed in other

parts of the world. Also subject to licensing and

security requirements, where required.

www.dotindia.com

PN 9 / 2000

d. Manufacture of

telecom equipments

100% Automatic Subject to sectoral requirements.

www.dotindia.com

PN 2 / 2000

26. Trading

a.

b.

c.

d.

e.

Wholesale/cash

& carry trading

Trading for

exports

Trading of items

sourced from small

scale sector

Test marketing of

such items for

which a co. has

approval for

Manufacture

Single Brand

product retailing

100%

100%

100%

100%

51%

Automatic

Automatic

FIPB

FIPB

FIPB

Subject to guidelines for

FDI in trading issued by Department of

Industrial Policy & Promotion vide Press Note 3

(2006 Series).

PN 4 / 2006

27. Satellites -

Establishment and

operation

74% FIPB Subject to Sectoral guidelines issued by

Department of Space/ISRO www.isro.org

28. Special Economic

Zones and Free

Trade

Warehousing

Zones covering

setting up of

these Zones and

setting up units

in the Zones

100% Automatic Subject to Special Economic Zones Act, 2005

and the Foreign Trade Policy.

www.sezindia.nic.in

PN 9 /

2000,

PN 2/2006

PN 4 /

2006

ANNEXURE IV

RESEARCH CONTRIBUTION

Name of the Scholar : Syed Khaja Safiuddin

Registration No : 0703PH1325

A. List of Papers published in Journals:

1. Safiuddin S.K. and Murthy S.S., “FDI in the Post-liberalization period – A

Study with special reference to Pharmaceutical Sector”, Advances in

Management, Vol. 4 (12) December 2011,Pp. 46-52 (ISSN No. 0974-2611)

(Published)

2. Safiuddin S.K. and Murthy S.S., “Financial Performance of FDI and Non-FDI

Companies in the Indian Pharmaceutical Sector - A Comparative Study”,

International Review of Business and Finance, Vol. 3 No. 2, July -Dec 2011,

Pp. 133-150 (ISSN No. 0976-5891) (Published)

3. Safiuddin S.K., “ Is Micro finance a Profit maximizing industry or a Social

Business- Some evidences from Recent literature survey”, Indian Journal of

Commerce & Management Studies, Vol. II Issue I, Feb-Mar 2011, Pp. 138-

145. (ISSN No. 2229-5674) (Published)

4. Safiuddin S.K., “Tourism Industry In Andhra Pradesh And Its Financial

Performance- A Study of APTDC”, Asia Pacific Business Review, Vol. VI No.

IV, Oct-Dec 2010, Pp. 154 – 166 (ISSN No. 0973-2470) (Published)

5. Safiuddin S.K. and Murthy S.S., “Foreign Direct Investment in Indian

Industry- A Study”, Indian Journal of International Business & Finance, Vol.

1 No.1-2, Jan- Dec 2011, Pp. 9-17 (ISSN No. 2249-4200) (Published)

6. Safiuddin S.K., “Foreign Direct Investment in India- Opportunities and

Benefits”, Global Journal of Finance & Management, Vol. II Issue II, July-Dec

2010, Pp. 245-259 (ISSN No. 0975 -6477) (Published)

7. Safiuddin S.K., “Hindustan mein Beruni Rast Sarmayakari”, Yojana (Urdu)

,Issue.12, Dec 2010 , Pp. 59-60 (ISSN No. 0971-8338) (Published)

8. Safiuddin S.K.,“Capital Exporting Countries and Foreign Investment in

India”, Orient Journal of Law & Social Sciences, Vol. IX Issue IV, August

2010, Pp. 72-77 (ISSN No.0973-7480) (Published)

B. List of Papers presented/accepted at conferences and

seminars:

1. Safiuddin S.K. and Murthy S.S., “Foreign Direct Investment Inflows In India:

Capital Exporting Countries Or General Public, Who Is At A Benefit?”, Seventh

International Seminar on Financial Markets: Issues and Challenges-(FIM IC-

2012), Department of Commerce and Financial Studies, Bharathidasan

University, Tiruchirappalli, 07th and 08th , Jan 2012. (Accepted)

2. Safiuddin S.K. and Murthy S.S., “ FDI in Education in India- Options and

Prospects”, National Seminar on "“Management Education in India –

Opportunities and Challenges(Focus on Rural Institutions), Telangana

University, 21st and 22nd October, 2011. (Presented)

3. Safiuddin S.K. and Murthy S.S., “ FDI in India and Indian Pharmaceutical

Industry”, International Conference on "Emergence of India as Global

Economic Superpower: Fiction or Future?, Department of Economics

(Postgraduate & Research Centre),Poona College Of Arts, Science & Commerce

Pune, 27th April, 2011. (Presented)

4. Safiuddin S.K., “ Microfinance in India- Reality or Myth”, International

Conference on "Emergence of India as Global Economic Superpower: Fiction

or Future?, Department of Economics (Postgraduate & Research

Centre),Poona College Of Arts, Science & Commerce Pune, 27th April, 2011.

(Presented)

5. Safiuddin S.K., “Foreign Direct Investment in India- A Sector-wise study”,

International Conference on International Trade and Commerce conducted,

Department of Commerce, Osmania University, 9th -11th January 2010.

(Presented)

6. Safiuddin S.K. and Murthy S.S., “FDI in India – A Study”, two-day

International Seminar on Recent Trends in Capital Markets and Financial

Innovations, Department of Commerce and Financial Studies, Bharathidasan

University, Tiruchirappalli, 9th -10th January, 2009. (Presented)

s.k.safiuddin thesis 0703ph1325 - revision...

Documents